SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bajasurfer who wrote (1073)4/16/1999 11:23:00 AM
From: Joe  Read Replies (1) of 1754
 
Baja

The problem I worry about is that if you have a Nidek that is not forced into a license agreement, it means that they can start selling their product without per use fees. Once one vendor is doing it, it will make it difficult for another to charge the fees.

I agree with you regarding Visx being the stock of a lifetime. A friend of mine worked for Visx. He had a 60,000 share stock option. He exercised and sold all when he left, at 13. He is still (or should be) kicking himself in the rear.

Joe (jpublic89)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News